FDA Inspection 1287710 — BCN Peptides SA

BCN Peptides SA — FEI 3008205509

The FDA completed an inspection of BCN Peptides SA on October 9, 2023 in Sant Quinti De Mediona. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 9, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sant Quinti De Mediona (Spain)

Additional Details

Mutual Recognition Agreement (MRA)